, 2008 FC 1185 (Alendronate*)

Justice Hughes - 2008-10-21

Read full decision. Automatically generated summary:

This is an action brought by the Plaintiff, Apotex Inc., under the provisions of section 8 of the Patented Medicines (Notice of Compliance) Regulations, SOR/93-133, as amended (PMNOC Regulations), claiming recovery against the Respondents, Merck Frosst Canada Ltd. and Merck Frosst Canada & Co. (collectively Merck). This is the first such action to proceed to trial on the merits. The parties have raised a number of preliminary issues for determination at this time, leaving the quantification of any award, if required, to a later trial.

Decision relates to:


Canadian Intellectual Property